AI Article Synopsis

  • CERM 3517, an antiemetic, was given to Beagle dogs to identify its major metabolite, which was found to have the same structure as a synthesized compound (CERM 4082).
  • The metabolite was produced through the cleavage of the aromatic part of CERM 3517.
  • After intravenous administration, 13% and 56% of doses of CERM 3517 and CERM 4082 were eliminated in urine as CERM 4082, indicating at least 25% of CERM 3517 was transformed via N-dephenylation.

Article Abstract

CERM 3517 (mociprazine), a new antiemetic compound, was administered orally at 10 mg/kg twice a day for 4 days to six Beagle dogs in order to identify the major metabolite. Mass spectrometric comparison of this metabolite and a synthesized reference compound (CERM 4082) showed that both had identical structures. The metabolite originated from cleavage of the aromatic moiety. After iv administration of CERM 3517 (0.9 mg/kg) and CERM 4082 (0.6 mg/kg) to five beagle dogs, 13% and 56% of the dose, respectively, were eliminated in the urine as CERM 4082 compound. It can be calculated that at least 25% of CERM 3517 was biotransformed by N-dephenylation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cerm 3517
16
beagle dogs
12
cerm 4082
12
3517 mociprazine
8
mass spectrometric
8
cerm
6
n-dephenylation cerm
4
0
4
mociprazine beagle
4
dogs mass
4

Similar Publications

N-dephenylated and N-phenyl urinary metabolites of mociprazine (CERM 3517) in beagle dogs after oral administration. A mass spectrometric determination.

Eur J Drug Metab Pharmacokinet

November 1991

Groupe de Recherches en Biodynamique du médicament, Laboratoire de Chimie analytique, Clermont-Ferrand, France.

CERM 3517 (mociprazine), a new anti-emetic compound, was administered orally to six beagle dogs at 10 mg/kg b.i.d.

View Article and Find Full Text PDF
Article Synopsis
  • CERM 3517, an antiemetic, was given to Beagle dogs to identify its major metabolite, which was found to have the same structure as a synthesized compound (CERM 4082).
  • The metabolite was produced through the cleavage of the aromatic part of CERM 3517.
  • After intravenous administration, 13% and 56% of doses of CERM 3517 and CERM 4082 were eliminated in urine as CERM 4082, indicating at least 25% of CERM 3517 was transformed via N-dephenylation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!